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Abstract
Background
Optimization of polymerase chain reaction (PCR)-based diagnostics requires the careful
selection of molecular targets that are both highly repetitive and pathogen-specific.
Advances in both next-generation sequencing (NGS) technologies and bioinformatics-
based analysis tools are facilitating this selection process, informing target choices and
reducing labor. Once developed, such assays provide disease control and elimination pro-
grams with an additional set of tools capable of evaluating and monitoring intervention suc-
cesses. The importance of such tools is heightened as intervention efforts approach their
endpoints, as accurate and complete information is an essential component of the informed
decision-making process. As global efforts for the control and elimination of both lymphatic
filariasis and malaria continue to make significant gains, the benefits of diagnostics with
improved analytical and clinical/field-based sensitivities and specificities will become
increasingly apparent.
Methodology/Principal findings
Coupling Illumina-based NGS with informatics approaches, we have successfully identified
the tandemly repeated elements in both the Wuchereria bancrofti and Plasmodium falcipa-
rum genomes of putatively greatest copy number. Utilizing these sequences as quantitative
real-time PCR (qPCR)-based targets, we have developed assays capable of exploiting the
most abundant tandem repeats for both organisms. For the detection of P. falciparum, anal-
ysis and development resulted in an assay with improved analytical and field-based sensitiv-
ity vs. an established ribosomal sequence-targeting assay. Surprisingly, analysis of the W.
bancrofti genome predicted a ribosomal sequence to be the genome’s most abundant
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tandem repeat. While resulting cycle quantification values comparing a qPCR assay target-
ing this ribosomal sequence and a commonly targeted repetitive DNA sequence from the lit-
erature supported our finding that this ribosomal sequence was the most prevalent
tandemly repeated target in the W. bancrofti genome, the resulting assay did not signifi-
cantly improve detection sensitivity in conjunction with field sample testing.
Conclusions/Significance
Examination of pathogen genomes facilitates the development of PCR-based diagnostics
targeting the most abundant and specific genomic elements. While in some instances cur-
rently available tools may deliver equal or superior performance, systematic analysis of
potential targets provides confidence that the selected assays represent the most advanta-
geous options available and that informed assay selection is occurring in the context of a
particular study’s objectives.
Introduction
Human malaria and lymphatic filariasis (LF), are mosquito-transmitted tropical diseases that
disproportionately affect economically disadvantaged nations. Due to their public health
impact and resulting economic burden, elimination efforts for these diseases continue to
expand with assistance from large-scale collaborative operations such as the Global Malaria
Programme [1–2] and the Global Programme to Eliminate Lymphatic Filariasis (GPELF) [3].
Thanks to such coordinated undertakings, significant strides are being made to reduce the
incidences of both diseases. However, as the trend towards elimination continues, and disease
incidence declines, accurate programmatic decision-making will require the development of
new and improved diagnostic tools with the capacity to reliably assess infection status and
measure intervention success.
Currently, World Health Organization (WHO)-recommended methods for the detection
of both malaria and lymphatic filariasis (LF) rely upon either the microscopic examination of
blood samples or serological antigen/antibody testing [4–6]. While widely used and important
for programmatic decision making processes [7–9], these approaches are dependent upon
human blood sampling and considerable evidence exists demonstrating the potential for these
testing methods to lead to both false-positive and false-negative results [6, 10–12]. While
requiring more advanced infrastructure, DNA-based assays utilizing quantitative real-time
polymerase chain reaction (qPCR), are able to improve upon diagnostic sensitivity and speci-
ficity of detection for these diseases [6, 13–14]. PCR-based assays also enable the testing of
sample types other than blood. Most importantly, in the context of LF and malaria, this capac-
ity allows researchers to indirectly and non-invasively sample a population using unique meth-
ods such as molecular xenomonitoring (MX): the testing of hematophagous arthropods for the
presence of parasite-derived genetic material [15–18].
While PCR-based assays targeting the causative agents of LF and human malaria have
existed for over two decades [19–20], recent advances in genome biology, next-generation
sequencing (NGS), and bioinformatics are facilitating increasingly systematic approaches to
assay design [21]. Through the computational analysis of whole genome sequencing data,
highly repetitive, species-specific, tandemly repeated DNA elements can be readily and rapidly
identified [22–23]. These sequences can then be utilized as PCR targets, resulting in significant
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improvements to both analytical and clinical/field sensitivity and specificity of detection when
compared with less prevalent, more conserved regions that have traditionally been employed
[21, 24–26]. Under experimental conditions, such targets result in reduced cycle quantification
(Cq) values for a given concentration of template DNA. Of greater diagnostic relevance,
repeat-based assays have the potential to lower an assay’s detection threshold as the increased
representation of the targets within the genome improves the probability that a given fragment
of DNA may contain a target sequence. This improves the robustness of such an assay, helping
to facilitate detection from impure or degraded samples, as well as samples resulting from sub-
optimal extractions. Improvements to robustness are particularly pronounced when assay tar-
gets are tandemly repeated, as random shearing or degradation of DNA is likely to leave a
greater number of target regions intact. As such, the utilization of highly repetitive, tandemly
repeated targets generates improved confidence in results due to greater diagnostic sensitivity.
With intervention efforts continuing to reduce infection frequency and parasite burden, the
importance of assay sensitivity and reliability has been magnified, making such detection
methods increasingly critical to successful programmatic efforts.
In an attempt to improve upon the analytical and field sensitivities of PCR-based pathogen
detection for the causative agents of LF and human malaria, we here describe the development
of two novel, TaqMan-based, qPCR assays targeting Wuchereria bancrofti and Plasmodium fal-
ciparum. Utilizing next-generation sequencing, the most highly repetitive tandemly repeated
targets within each genome were identified. Index assays targeting these high copy-number
DNA sequences were then designed, optimized, and validated against existing reference qPCR
assays using field-collected samples. Comparison with these existing qPCR assays supported
our target copy-number predictions, as Cq values were reduced when targeting the newly
identified repeat elements from both organisms. Primarily for P. falciparum detection, these
reductions in Cq value translated to improved field sensitivity, reducing false negative results
through the detection of an increased number of positive samples.
Materials and methods
Next-generation sequencing and repeat DNA analysis
In preparation for next-generation sequencing (NGS), W. bancrofti var. Pacifica genomic
DNA was isolated from microfilariae originally obtained from a Polynesian donor [27]. Geno-
mic DNA from Plasmodium falciparum, Strain W2, MRA-157G was provided by BEI
Resources. For each pathogen, library preparations for NGS were performed using the Nextera
DNA Library Prep Kit (Illumina, San Diego, CA) in accordance with the manufacturer’s sug-
gested protocol. Paired-end sequencing of the prepared libraries occurred on the MiSeq
instrument (Illumina) using a v3 150-cycle reagent kit (Illumina) for W. bancrofti and a v2
300-cycle kit (Illumina) for P. falciparum. Sequence reads were analyzed using default parame-
ters for both RepeatExplorer2 [22] and Tandem Repeat Analyzer (TAREAN) [23], Galaxy-
based tools designed to identify repetitive DNA elements and satellite DNA sequences from
paired-end whole genome sequencing data (publically available at galaxy-elixir.cerit-sc.cz).
While we have previously described the use of RepeatExplorer for assay development purposes
[24–26], TAREAN builds upon the algorithms developed for RepeatExplorer. Whereas, Repea-
tExplorer identifies and bins NGS sequence reads into clusters based on similarity, and then
ranks those clusters based on the number of reads binned [22], TAREAN identifies clusters
that are predicted to have a tandem arrangement within the genome and builds consensus
sequences for these clusters. These predictions of tandem arrangement are based upon the
identities and abundances of DNA sequences that flank elements mapping to the consensus
[23]. The output of TAREAN is a list of putative tandemly repeated sequences built from each
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predicted cluster. From the output generated from both RepeatExplorer2 and TAREAN, tar-
gets for each qPCR assay were chosen.
Assay design
Target selection. Utilizing consensus sequences, monomer lengths, and putative esti-
mates of genomic proportions resulting from RepeatExplorer2 and TAREAN analyses, a can-
didate target from each pathogen was selected for further validation. For both W. bancrofti
and P. falciparum, these candidate targets were predicted to be the genomic elements of great-
est copy number having tandem arrangement and sufficient length to facilitate the design of a
qPCR assay. Utilizing default parameters of the PrimerQuest Tool (Integrated DNA Technolo-
gies, Coralville, IA) TaqMan-based assays (hereafter referred to as the W. bancrofti Tandem
Repeat #1 [Wb TR1] and P. falciparum Tanderm Repeat #1 [Pf TR1] assays) were designed for
both targets, and a forward primer, reverse primer, and double-quenched 6FAM-ZEN/
3IABkFQ probe (Integrated DNA Technologies) were synthesized.
Primer optimization. For each assay, optimal forward and reverse primer concentrations
were determined using a previously described concentration matrix [24]. Briefly, five concen-
trations of forward and reverse primers (1 μM, 500 nM, 250 nM, 125 nM, 62.5 nM) were tested
in every possible pairing, resulting in a 5 x 5 matrix testing 25 experimental combinations. All
testing was performed in duplicate 10 μL reactions containing 5 μL of TaqPath ProAmp Mas-
ter Mix (ThermoFisher Scientific, Waltham, MA), 2 μL of primer mix diluted to each appro-
priate experimental concentration, and 250 nM probe. Reactions were performed using the
StepOnePlus Real-Time PCR System (ThermoFisher Scientific). Cycling conditions for both
assays consisted of an initial hold at 50˚C for 2 minutes, followed by a 10 minute incubation at
95˚C. Following incubation, 40 cycles of 95˚C for 15 seconds and 60˚C for 1 minute were per-
formed to allow for denaturation of template and annealing/extension of primers respectively.
Optimal primer concentrations for each assay were determined to be the paired concentra-
tions which produced the lowest mean Cq values.
Validation of analytical specificity. In-silico specificity was analyzed for each assay using
Primer-BLAST, a primer alignment software from the National Center for Biotechnology
Information (NCBI). All alignments were performed against NCBI’s RefSeq representative
genomes database. Subsequent experimental validation was then performed by testing against
a panel of genomic DNA isolates from both closely and more distantly related pathogens as
well as human DNA. Finally, to ensure that each assay would successfully allow for the amplifi-
cation of the intended target from geographically distinct isolates of pathogen, testing of eight
different DNA extracts of P. falciparum genomic DNA obtained from BEI Resources (www.
beiresources.org) was performed, as was the testing of W. bancrofti-positive DNA extracts
from mosquito samples originating from six independent locations (American Samoa, French
Polynesia, Ghana, Haiti, Sri Lanka, Tuvalu, and Zanzibar). All validation reactions were per-
formed in duplicate using the optimized assay conditions and the cycling protocol described
above.
Template titration. To evaluate the reaction efficiencies and analytical sensitivities of our
newly described qPCR assays and to compare them with currently employed qPCR assays [16,
28], template limiting experiments were performed. Sequences and references for “long DNA
repeat” (LDR) sequence-targeting (W. bancrofti detection) and ribosomal sequence-targeting
(P. falciparum) primer-probe pairings used during this testing are found in Table 1. For each
assay, 1:10 serial dilutions of genomic DNA were created, generating a panel of standards with
concentrations ranging from 0.5 ng/μL to 50 ag/μL. Dilution panels were then tested, with
each concentration undergoing analysis in triplicate 10 μL reactions. These reactions were
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performed using 2 μL of template and with the primer concentrations determined to be opti-
mal for each assay. Each assay’s reaction efficiency was determined using the mean Cq values
resulting from analysis of the five reactions with the highest input amount of DNA (1 ng, 100
pg, 10 pg, 1 pg, and 100 fg). Subsequently, for each pathogen, the lowest concentration of tem-
plate at which both assays undergoing comparison produced three replicate positive reactions
was identified. This concentration was then used to generate a second dilution series consist-
ing of eight doubling dilutions. Eight replicates of each dilution within this second series were
then tested with both our new and the existing qPCR assays, and comparative analytical sensi-
tivities were evaluated based on the percentage of positive results obtained.
Assay validation using field samples. To evaluate the field sensitivity and specificity of
our new qPCR assays, each assay was tested using a set of DNA extracts isolated from field-col-
lected mosquito pools gathered as part of two unrelated studies. For the detection of W. ban-
crofti, 436 samples collected from Haiti (n = 238) and Zanzibar (n = 198) were tested in
duplicate reactions utilizing the optimized primer/probe concentrations described above. The
results for each sample were compared to results obtained using the previously described LDR
qPCR assay run in accordance with published conditions [16]. For the detection of P. falcipa-
rum, comparative testing of 616 samples, collected in Ghana, was performed using both our
newly described index assay and a previously published reference assay targeting the 18S ribo-
somal sequence [28]. Selection of these assays as reference standards was based upon preva-
lence of use within the research community and/or frequency of selection of the assay target
region as a qPCR target for the pathogen. As was the case for W. bancrofti detection, all P. fal-
ciparum reactions were performed in duplicate, using optimized and/or published reaction
conditions. Building on previously published conventions [29], for all testing, a sample was
considered positive if both replicate reactions produced Cq values� 40. In the event that only
one replicate reaction produced a positive result, the sample was re-tested in duplicate, and
positivity was confirmed if at least one re-test replicate produced a positive result with a Cq
value� 40. Upon retesting, if neither replicate amplified with a Cq value� 40, the sample was
considered negative. In all cases of retesting, only retest results were reported. Of note, while
technicians were not blinded to results summaries for comparator assays during sample pro-
cessing, comparative individual sample results were not made available during the time of
testing.
Results
Next generation sequencing, repeat analysis, and target selection
Illumina sequencing of P. falciparum produced 4.3 million paired-end reads of which 86.4%
passed the filter for read quality with a quality (Q) score� 35 (inferred base call accuracy of
Table 1. Primer/probe sequences and reference information for LDR-targeting and ribosomal sequence-targeting assays used for comparative testing with index
assays.
Wuchereria bancrofti 5’! 3’ Orientation Relevant Reference
Forward Primer ATTTTGATCATCTGGGAACGTTAATA Rao et al, 2006 [16]
Reverse Primer CGACTGTCTAATCCATTCAGAGTGA
Probe ATCTGCCCATAGAAATAACTA
Plasmodium falciparum 5’! 3’ Orientation Relevant Reference
Forward Primer ATTGCTTTTGAGAGGTTTTGTTACTTT Kamau et al, 2013 [28]
Reverse Primer GCTGTAGTATTCAAACACAATGAACTCAA
Probe CATAACAGACGGGTAGTCAT
https://doi.org/10.1371/journal.pone.0232325.t001
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99.95%). W. bancrofti paired-end sequencing produced 15 million reads, of which 83.4%
passed filter with a Q score� 35. For each library, 500,000 reads of uniform length (75bp for
Wb and 100bp for Pf) were then randomly selected for analysis using RepeatExplorer2 and/or
TAREAN, allowing for the generation of clusters and the identification of consensus
sequences. For both pathogens, highly represented clusters were selected based upon the num-
ber of component reads in conjunction with the length of the repeat sequence. Selected repeat
clusters were estimated to represent 0.320% and 1.300% of the W. bancrofti and P. falciparum
read totals respectively. Utilizing the consensus sequences for each selected cluster, Primer-
Quest Software was next used to select primer-probe pairings for use in the development of a
TaqMan-based qPCR assay for each target (Table 2). A Primer-BLAST analysis then provided
preliminary in silico evidence that each assay would amplify DNA only from its intended target
species.
Assay design
Assay optimization. Utilizing a matrix of doubling dilutions, primers were titrated to
determine optimal concentrations for use in each assay. Based on resulting mean Cq values,
final reaction concentrations for the new P. falciparum assay were determined to be 1 μM for
both the forward and reverse primers (S1 Table). Optimal concentrations for the W. bancrofti
assay were 125 nM for the forward primer and 1 μM for the reverse primer (S2 Table).
Assay specificity. To verify the species-level specificity of both newly developed assays,
optimized primer/probe pairings were tested against a panel of parasite gDNA extracts,
human gDNA, and DNA extracted from mosquitoes or human blood containing target para-
sites from various geographic locations. For both assays, amplification was only observed from
reaction wells containing the appropriate target DNA. No off-target-amplification results were
observed (Tables 3 and 4).
Table 2. Primer and probe sequences for the newly described qPCR assays targeting the greatest copy-number tandem repeats.
Target Species Forward Primer (5’!3’) Reverse Primer (5’!3’) Probe (5’!3’)
Wuchereria bancrofti GCTGAAAAACATTCGCTTTTGAATG GGGTAATTAAACCGGTGATCCT ACAACAACTATATGGGAATGGTGCAGGT
Plasmodium falciparum GTTACCATAAGACCTATATGAATGAAAG GGTCTTAAATTGAGTAACTAAGATCA ACGTAGGTCTTACATTAACTAACTCAGGTC
https://doi.org/10.1371/journal.pone.0232325.t002
Table 3. Results of validation testing for the Wb TR1 assay.
Species Source Result
Acanthocheilonema viteae Genomic DNA -
Brugia malayi Genomic DNA -
Brugia pahangi Genomic DNA -
Dirofilaria immitis Genomic DNA -
Loa loa Genomic DNA -
Onchocerca volvulus Genomic DNA -
Human Genomic DNA -
Wuchereria bancrofti (American Samoa) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (French Polynesia) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (Ghana) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (Haiti) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (Sri Lanka) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (Tuvalu) DNA Extract of Infected Mosquito +
Wuchereria bancrofti (Zanzibar) DNA Extract of Infected Mosquito +
https://doi.org/10.1371/journal.pone.0232325.t003
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Reaction efficiency. Utilizing a titration of gDNA template, a reaction efficiency was cal-
culated for each assay. Efficiencies were determined using the mean Cq results obtained for
testing of template at masses of 2 ng, 200 pg, 20 pg, 2 pg, and 200 fg per reaction. Reaction effi-
ciencies were determined using the qPCR library quantification tool available from the NEBio-
Calculator website (https://nebiocalculator.neb.com/#!/qPCRlibQnt) and can be found in
Table 5.
Validation of genome copy number. Comparisons of Cq values across gDNA template
concentrations produced average reductions in Cq value of 2.91 for the new Wb TR1 assay
compared to the Wb LDR assay and 1.19 for the new Pf TR1 assay compared to the Pf Ribo-
somal assay (Table 6). While Cq value comparisons alone do not provide a meaningful mea-
sure of relative assay sensitivities, when similar reaction efficiencies exist, such values can
provide useful information about genome target content, with reduced Cq values generally
corresponding to increases in target copy number. Accordingly, these results provide evidence
in support of the informatics-based output underlying our assay design.
Comparative analytical sensitivities. To investigate the comparative analytical sensitivi-
ties of our assays, a series of doubling dilutions of gDNA template were tested comparing the
Wb TR1 and Wb LDR assays and the Pf TR1 and Pf Ribosomal assays. For both comparisons,
the template dilution series began at the experimentally determined limit of consistent detec-
tion, meaning the final mass of template at which both assays being compared allowed for con-
sistent detection of pathogen signal upon testing in octuplicate reactions. For detection of P.
falciparum, this limit occurred at the 100 fg level. For detection of W. bancrofti, this limit was
found to be 10 fg. Fig 1 reflects the percentage of replicate positivity for each assay as the input
DNA was decreased. For both pathogens, the analytical sensitivity of each assay began to
decline at comparable dilutions. When detecting P. falciparum, the ribosomal assay began to
demonstrate inconsistent positivity at the 50 fg level while the new Pf TR1 assay was no longer
consistent beginning at 25 fg (Fig 1A). For W. bancrofti detection, the Wb TR1 assay lacked
Table 4. Results of validation testing for the Pf TR1 assay.
Species Source Result
Acanthocheilonema viteae Genomic DNA -
Brugia malayi Genomic DNA -
Brugia pahangi Genomic DNA -
Dirofilaria immitis Genomic DNA -
Homo Sapiens Genomic DNA -
Loa loa Genomic DNA -
Onchocerca volvulus Genomic DNA -
Plasmodium cynomolgi Genomic DNA -
Plasmodium knowlesi Genomic DNA -
Plasmodium vivax DNA Extract of Infected Mosquito -
Plasmodium falciparum (Strain 3D7) Genomic DNA +
Plasmodium falciparum (Strain 7G8) Genomic DNA +
Plasmodium falciparum (Strain HB3-B2) Genomic DNA +
Plasmodium falciparum (Strain D6) Genomic DNA +
Plasmodium falciparum (Strain DD2) Genomic DNA +
Plasmodium falciparum (Strain FCB) Genomic DNA +
Plasmodium falciparum (Strain FCR3CSA) Genomic DNA +
Plasmodium falciparum (Strain W2) Genomic DNA +
https://doi.org/10.1371/journal.pone.0232325.t004
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consistency beginning at the 5 fg level, while the LDR-targeting assay remained consistent
until the 2.5 fg level (Fig 1B).
Assay validation using field samples. To further evaluate comparative assay performance
and to gauge field sensitivity and specificity, panels of mosquito DNA extracts were employed.
Six hundred and sixteen extracts were tested utilizing both the Pf TR1 assay and Pf Ribosomal
assay. This testing resulted in 179 samples which were positive utilizing the newly described Pf
TR1 assay, but only 161 positive samples when testing with the ribosomal sequence-targeting
assay. Of the Pf TR1 positive samples, 25 produced a negative result when tested with the Pf
ribosomal assay, while only seven samples were positive using the ribosomal-targeting assay,
but negative when tested using the Pf TR1 assay (Table 7). Recognizing any sample which
tested positive by either assay to be a true positive, the sensitivity of the Pf TR1 assay was deter-
mined to be 96.24%, while the P. falciparum assay utilizing the ribosomal target had a sensitiv-
ity of 86.56%. In contrast, the Wb TR1 assay identified only a single positive sample that was
determined to be negative utilizing the LDR assay, while testing with the LDR assay did not
result in any positive samples that were undetected during Wb TR1 assay testing (Table 8).
Discussion
Given the wide-ranging global health impacts of both LF and malaria, the ability to accurately
assess disease prevalence and burden is paramount. Though current DNA-based assays have
vastly improved our ability to detect the causative agents of these diseases within a variety of
sample types, the use of potentially sub-optimal targets can lead to both false-negative and
false-positive results. Such results can negatively influence public health outcomes through
their costly impacts on programmatic elimination efforts, improperly influencing decision-
making processes and leading to economic losses.
With the help of next-generation sequencing, we have previously demonstrated that
improvements in analytical and field sensitivity of qPCR-based diagnostic assays can be
achieved through the identification and targeting of an organism’s tandemly repeat sequences
of greatest copy number [24–26]. Similarly, a growing number of recent studies have demon-
strated that the ability to accurately attribute infection to the proper causative agent is signifi-
cantly impacted by the diagnostic target selected (reviewed in [26]). Understanding these
challenges, and with a goal of improving existing tools, we have sought to identify and diagnos-
tically exploit robust targets within the genomes of both W. bancrofti and P. falciparum. As
reported above, these objectives were largely achieved with the development of the Pf TR1
Table 5. Reaction efficiencies for each assay utilized during experimental testing.
Assay Wb TR1 Wb LDR Pf TR1 Pf Ribosomal
Efficiency 98.44% 96.06% 89.91% 93.43%
https://doi.org/10.1371/journal.pone.0232325.t005
Table 6. Comparison of mean Cq values for index and reference assays.
Wb TR1 Mean Cq (±SD) Wb LDR Mean Cq (±SD) Difference in Means Pf TR1 Mean Cq (±SD) Pf Ribosomal Mean Cq (±SD) Difference in Means
1 ng 13.81 (±0.14) 16.67 (±0.09) 2.86 17.76 (±0.06) 19.13 (±0.18) 1.37
100
pg
17.11 (±0.09) 19.92 (±0.03) 2.81 21.14 (±0.19) 22.51 (±0.10) 1.37
10 pg 20.41 (±0.08) 23.20 (±0.05) 2.79 24.61 (±0.06) 25.85 (±0.08) 1.25
1 pg 24.06 (±0.17) 26.95 (±0.18) 2.88 28.36 (±0.02) 29.23 (±0.19) 0.87
100 fg 27.10 (±0.31) 30.32 (±0.14) 3.22 32.06 (±0.36) 33.16 (±0.43) 1.11
Mean 2.91 1.19
https://doi.org/10.1371/journal.pone.0232325.t006
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assay, as both analytical and field sensitivities were improved. In contrast, improvements were
much more modest when the Wb TR1 assay was compared against the commonly utilized Wb
LDR assay for detection of W. bancrofti. While an analysis of comparative Cq values demon-
strated the abundant nature of the Wb TR1 target, the resulting assay produced similar analyti-
cal and field sensitivities when compared with those obtained through testing with the
commonly employed Wb LDR assay. The underlying causes for this unexpected similarity in
sensitivities remain a mystery. One possibility could be that both assays were sufficient to
allow for the detection of all, or nearly all true positive samples, resulting in their equivalent
clinical performances. More surprising is the similarity of results seen during the testing of
analytical sensitivity, as the reduced Cq values for Wb TR1 testing did not translate into
improved limits of detection (Fig 1B). However, given that the analytical sensitivity for both
assays remained equivalent until concentrations of template were reduced to levels less than 10
fg/μL, it is possible that this homogenization of results simply reflects the stochastic variation
that is seen at these low levels of target. Given that a single microfilaria is estimated to contain
Fig 1. Analytical sensitivities of novel and published assays. Utilizing serial dilutions of gDNA template for each pathogen of interest, the final concentrations at
which the novel (Pf TR1 and Wb TR1) and published (Pf ribosomal and Wb LDR) assays both consistently detected their target templates were identified. Utilizing these
concentrations as starting points for each pathogen, a series of doubling dilutions was then created to further titrate the gDNA, and each assay was performed in
octuplicate using each titrated standard in the second panel as template. Consistency of amplification for each assay was then plotted as a percentage for both P.
falciparum-amplifying assays and both W. bancrofti-amplifying assays.
https://doi.org/10.1371/journal.pone.0232325.g001
Table 7. Comparative testing of field-caught mosquito DNA extracts using the Pf TR1 and Pf ribosomal assays.
Pf Ribosomal Assay
Pf TR1 Assay Negative Positive Total
Negative 430 7 437
Positive 25 154 179
Total 455 161 616
https://doi.org/10.1371/journal.pone.0232325.t007
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approximately 100 pg of genomic DNA [30], these results again suggest that both the LDR ref-
erence assay and the the Wb TR1 assay are likely sufficiently sensitive to detect all true positive
samples.
The results of our W. bancrofti repeat analysis present an interesting case. Previous analyses
of various other multicellular eukaryotic pathogens using the RepeatExplorer-based pipeline
have all suggested that the highest copy-number genomic elements are tandemly-repeated
non-coding satellite sequences [24–26, 31]. In all cases, these repeat targets have significantly
improved both the sensitivity and specificity of qPCR-based detection when compared to con-
ventionally used targets such as ribosomal DNA. Unexpectedly, our analysis of the W. ban-
crofti genome identified a ribosomal repeat, rather than a satellite repeat, as the tandemly-
repeated sequence element of putatively greatest copy number. Typically, such ribosomal tar-
gets raise concerns for potential cross-reactivity with closely related species due to the genetic
conservation of these DNA elements. While analytical specificity testing of the Wb TR1 assay
did not result in the false positive amplification of any related nematodes, testing against an
all-inclusive set of genetically similar species is difficult and impractical. As such, there remains
an increased risk for such cross-reactivity, and this risk should be considered when making
decisions about the most appropriate assay for use in a given study. Despite the greater target
copy number (as evidenced by comparative Cq values), improved confidence in specificity
may render the LDR-targeting assay the best choice for many applications. This is particularly
true considereing the similar analytical and clinical sensitivies seen during comparative
testing.
While our results suggest improved analytical sensitivity and field-based detection of P. fal-
ciparum using the Pf TR1 assay, it is important to note that P. falciparum is not the leading
cause of human malaria in WHO Region of the Americas, where Plasmodium vivax is most
prevalent [32]. Similarly, Plasmodium malariae and Plasmodium ovale are significant agents of
human disease. As such, the development of similar qPCR-based assays, with the capacity to
sensitively and specifically identify these related pathogens should be developed. Such assays
would be of use to global control and elimination efforts, while also aiding in accurate patho-
gen mapping, and furthering our understanding of species-specific responses to anti-malarial
drugs.
While PCR-based diagnostics continue to play an increasingly important role in many
neglected tropical disease control and elimination efforts, challenges pertaining to cost, infra-
structure, and expertise remain significant. Fortunately, current developmental efforts are
making PCR-based technologies increasingly accessible in resource limited settings, bridging
the capacity gap and enabling the rapid deployment of the most reliable diagnostic methods to
the areas where they are most urgently needed. As the global incidence of diseases such as LF
and malaria continues to decrease, coordinated elimination efforts will increasingly rely upon
optimal diagnostic options to confidently detect low levels of positivity, both within tested
communities and within individual samples. Such detection will accurately inform stopping
decisions facilitating the appropriate targeting of resources to where they are most urgently
needed.
Table 8. Comparative testing of field-caught mosquito DNA extracts using the Wb TR1 and Wb LDR assays.
Wb LDR Assay
Wb TR1 Assay Negative Positive Total
Negative 265 0 265
Positive 1 170 171
Total 266 170 436
https://doi.org/10.1371/journal.pone.0232325.t008
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